J. Dupuis

发表

Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure.

M. Gladwin, C. Long, L. Leinwand, 2006, Circulation.

Short-Term Administration of a Cell-Permeable Caveolin-1 Peptide Prevents the Development of Monocrotaline-Induced Pulmonary Hypertension and Right Ventricular Hypertrophy

M. Lisanti, H. Tanowitz, I. Mercier, 2006, Circulation.

A Web-Based Tailored Intervention to Support Illness Management in Patients With an Acute Coronary Syndrome: Pilot Study

M. Gagnon, G. Fontaine, S. Cossette, 2017, JMIR cardio.

Urocontrin, a novel UT receptor ligand with a unique pharmacological profile.

M. Létourneau, A. Fournier, J. Dupuis, 2012, Biochemical pharmacology.

Cellular and molecular basis of pulmonary arterial hypertension.

N. Weissmann, P. Thistlethwaite, S. Archer, 2009, Journal of the American College of Cardiology.

Reduction in hepatic endothelin-1 clearance in cirrhosis.

J. Dupuis, L. Villeneuve, A. Schwab, 2003, Clinical science.

The endothelin system in pulmonary hypertension.

R. Michel, D. Langleben, J. Dupuis, 2003, Canadian journal of physiology and pharmacology.

L-arginine prevents cyclosporin A-induced pulmonary vascular dysfunction.

M. Carrier, J. Dupuis, L. Pelletier, 1997, The Annals of thoracic surgery.

In vivo measurement of coronary circulation angiotensin-converting enzyme activity in humans.

R. Gallo, J. Lespérance, G. Gosselin, 2003, American journal of physiology. Heart and circulatory physiology.

Bosentan does not improve pulmonary hypertension and lung remodeling in heart failure

J. Tardif, Yanfen Shi, J. Dupuis, 2010, European Respiratory Journal.

Human pulmonary circulation is an important site for both clearance and production of endothelin-1.

D. Stewart, G. Gosselin, J. Dupuis, 1996, Circulation.

Nitrates in congestive heart failure

J. Dupuis, 1994, Cardiovascular drugs and therapy.

Downregulation of the Endothelin System of Lung Myofibroblasts in Congestive Heart Failure

J. Dupuis, A. Calderone, A. Préfontaine, 2009, Journal of cardiovascular pharmacology.

Modification of the pulmonary renin-angiotensin system and lung structural remodelling in congestive heart failure.

A. Caron, J. Dupuis, L. Villeneuve, 2006, Clinical science.

Reduced pulmonary clearance of endothelin in congestive heart failure: a marker of secondary pulmonary hypertension.

M. White, A. Caron, G. Gosselin, 2004, Journal of cardiac failure.

Single measurement of troponin T for early prediction of infarct size, congestive heart failure, and pulmonary hypertension in an animal model of myocardial infarction.

J. Tardif, Yanfen Shi, J. Dupuis, 2011, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

Reduced pulmonary clearance of endothelin-1 in pulmonary hypertension.

J. Tardif, D. Stewart, G. Gosselin, 1998, American heart journal.

Reduced pulmonary clearance of endothelin-1 contributes to the increase of circulating levels in heart failure secondary to myocardial infarction.

J. Rouleau, J. Dupuis, P. Cernacek, 1998, Circulation.

Infection, Endothelial Dysfunction, and Atherogenesis

P. Khairy, S. Rinfret, S. Shapiro, 2003 .

SPECT)ission computed tomography Physiological imaging of the lung

D. Bailey, M. Létourneau, A. Fournier, 2015 .

Mechanisms of acute coronary syndromes and the potential role of statins.

J. Dupuis, 2001, Atherosclerosis. Supplements.

A pilot study: the Noninvasive Surface Cooling Thermoregulatory System for Mild Hypothermia Induction in Acute Myocardial Infarction (the NICAMI Study).

H. Ly, A. Denault, A. Arsenault, 2005, American heart journal.

Role of aldosterone on lung structural remodelling and right ventricular function in congestive heart failure

J. Tardif, Yanfen Shi, J. Dupuis, 2011, BMC cardiovascular disorders.

Chronically elevated endothelin levels reduce pulmonary vascular reactivity to nitric oxide.

N. Leblanc, A. Fournier, É. Thorin, 2005, American journal of respiratory and critical care medicine.

Bone marrow-derived progenitor cells contribute to lung remodelling after myocardial infarction.

J. Dupuis, L. Villeneuve, A. Calderone, 2007, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

Intensity of lipid lowering with statins and brachial artery vascular endothelium reactivity after acute coronary syndromes (from the BRAVER trial).

E. Lonn, J. Rouleau, C. Cannon, 2005, The American journal of cardiology.

PulmoBind, an Adrenomedullin-Based Molecular Lung Imaging Tool

M. Létourneau, A. Fournier, J. Dupuis, 2013, The Journal of Nuclear Medicine.

Role of ETA receptors in the regulation of vascular reactivity in rats with congestive heart failure

É. Thorin, J. Dupuis, P. Cernacek, 2000 .

Expression of Phosphoinositide-Specific Phospholipase C Isoforms in Native Endothelial Cells

J. Tardif, D. Béziau, J. Dupuis, 2015, PloS one.

Evaluation of Luminal Endothelin-Converting Enzyme Activity in the Pulmonary and Coronary Circulations

J. Dupuis, J. Jasmin, 2004, Journal of cardiovascular pharmacology.

Metabolic Syndrome Exacerbates Pulmonary Hypertension due to Left Heart Disease.

P. Pibarot, S. Archer, A. Marette, 2019, Circulation research.

Lung structural remodeling and pulmonary hypertension after myocardial infarction: complete reversal with irbesartan.

J. Dupuis, L. Villeneuve, J. Jasmin, 2003, Cardiovascular research.

Impact of Pituitary–Gonadal Axis Hormones on Pulmonary Arterial Hypertension in Men

Z. Jing, J. Dupuis, Xin Jiang, 2018, Hypertension.

Endothelin receptor antagonists in pulmonary arterial hypertension

M. Hoeper, J. Dupuis, M. Hoeper, 2008, European Respiratory Journal.

Activation of the right ventricular endothelin (ET) system in the monocrotaline model of pulmonary hypertension: response to chronic ETA receptor blockade.

J. Dupuis, J. Jasmin, P. Cernacek, 2003, Clinical science.

Animal Models of Pulmonary Hypertension

N. Weissmann, J. Dupuis, 2011 .

vessels in canine pacing-induced heart failure Remodeling of lung interstitium but not resistance

C. L. Ivey, M. Swartz, R. Reed, 2015 .

Monocrotaline pyrrole induces pulmonary endothelial damage through binding to and release from erythrocytes in lung during venous blood reoxygenation.

Z. Jing, Jian-sha Li, J. Dupuis, 2019, American journal of physiology. Lung cellular and molecular physiology.

The pulmonary circulation is an important site for both clearance and production of endothelin-1 in humans

D. Stewart, G. Gosselin, J. Dupuis, 1996 .

Endothelin-3-dependent pulmonary vasoconstriction in monocrotaline-induced pulmonary arterial hypertension

É. Thorin, J. Dupuis, L. Villeneuve, 2008, Peptides.

SPECT imaging of pulmonary vascular disease in bleomycin-induced lung fibrosis using a vascular endothelium tracer

J. Tardif, M. Sirois, Yanfen Shi, 2021, Respiratory Research.

Molecular imaging of the human pulmonary vascular endothelium in pulmonary hypertension: a phase II safety and proof of principle trial

M. Guertin, M. Létourneau, A. Fournier, 2017, European Journal of Nuclear Medicine and Molecular Imaging.

PulmoBind Imaging Measures Reduction of Vascular Adrenomedullin Receptor Activity with Lack of effect of Sildenafil in Pulmonary Hypertension

J. Tardif, M. Létourneau, A. Fournier, 2019, Scientific Reports.

Characterization of iodinated adrenomedullin derivatives suitable for lung nuclear medicine.

M. Létourneau, A. Fournier, J. Dupuis, 2011, Nuclear medicine and biology.

Dietary Geranylgeranyl Pyrophosphate Counteracts the Benefits of Statin Therapy in Experimental Pulmonary Hypertension

J. Dupuis, Li-ping Zhu, Jianguo He, 2021, Circulation.

Calcium Sensing Receptor Variants Increase Pulmonary Hypertension Susceptibility

Z. Jing, J. Dupuis, Li-ping Zhu, 2022, Hypertension.

Molecular Imaging of the Human Pulmonary Vascular Endothelium Using an Adrenomedullin Receptor Ligand

M. Létourneau, A. Fournier, J. Dupuis, 2015, Molecular imaging.

Characterization of the adrenomedullin receptor acting as the target of a new radiopharmaceutical biomolecule for lung imaging.

M. Létourneau, A. Fournier, J. Dupuis, 2009, European journal of pharmacology.

Use of Adrenomedullin Derivatives for Molecular Imaging of Pulmonary Circulation

M. Létourneau, A. Fournier, A. Caron, 2008, Journal of Nuclear Medicine.

Biodistribution, plasma kinetics and quantification of single-pass pulmonary clearance of adrenomedullin.

A. Caron, J. Dupuis, Nathalie Ruël, 2005, Clinical science.

Phenylalanine Induces Pulmonary Hypertension Through Calcium-Sensing Receptor Activation.

Jian-sha Li, J. Dupuis, Li-ping Zhu, 2020, American journal of physiology. Lung cellular and molecular physiology.

Reduced pulmonary metabolism of endothelin-1 in canine tachycardia-induced heart failure.

G. Moe, J. Dupuis, P. Cernacek, 1998, Cardiovascular research.

Lung Capillary Stress Failure and Arteriolar Remodelling in Pulmonary Hypertension Associated with Left Heart Disease (Group 2 PH).

J. Dupuis, J. Ledoux, Nour R Dayeh, 2016, Progress in cardiovascular diseases.

Pulmonary clearance of circulating endothelin-1 in dogs in vivo: exclusive role of ETB receptors.

C. Goresky, A. Fournier, J. Dupuis, 1996, Journal of applied physiology.

LU135252, an endothelinA receptor antagonist did not prevent pulmonary vascular remodelling or lung fibrosis in a rat model of myocardial infarction

J. Rouleau, J. Dupuis, Q. Nguyen, 2000 .

Evaluation of Endothelin-1–Induced Pulmonary Vasoconstriction Following Myocardial Infarction

A. Caron, É. Thorin, J. Dupuis, 2006, Experimental biology and medicine.

Increased endothelin levels in congestive heart failure: does it come from the lungs? Does it matter?

J. Dupuis, 2004, Cardiovascular research.

Pulmonary clearance of circulating endothelin-1 in dogs in vivo: exclusive role of ETB receptors.

C. Goresky, A. Fournier, J. Dupuis, 1996, Journal of applied physiology.

Pulmonary removal and production of endothelin in the anesthetized dog.

D. Stewart, C. Goresky, J. Dupuis, 1994, Journal of applied physiology.

Evaluation of pulmonary perfusion by SPECT imaging using an endothelial cell tracer in supine humans and dogs

M. Létourneau, A. Fournier, J. Dupuis, 2016, EJNMMI Research.

Pathophysiology and clinical relevance of pulmonary remodelling in pulmonary hypertension due to left heart diseases.

M. Guazzi, J. Dupuis, 2015, The Canadian journal of cardiology.

Pathophysiology and Clinical Relevance of Pulmonary Remodelling in Pulmonary Hypertension due to Left Heart

M. Guazzi, J. Dupuis, 2015 .

Pulmonary metabolism of endothelin 1 during on-pump and beating heart coronary artery bypass operations.

M. Carrier, R. Cartier, J. Taillefer, 2001, The Journal of thoracic and cardiovascular surgery.

Effect of sternotomy and extracorporeal circulation on pulmonary neutrophil kinetics in pigs

Y. Merhi, J. Dupuis, L. Perrault, 2006, Basic Research in Cardiology.

Change in pharmacological effect of endothelin receptor antagonists in rats with pulmonary hypertension: role of ETB-receptor expression levels.

É. Thorin, J. Dupuis, L. Villeneuve, 2009, Pulmonary pharmacology & therapeutics.

Role of endothelin receptors on basal and endothelin-1-stimulated lung myofibroblast proliferation.

J. Dupuis, A. Calderone, A. Préfontaine, 2008, Canadian journal of physiology and pharmacology.

Endothelin: setting the scene in PAH

J. Dupuis, 2007, European Respiratory Review.

Endothelin-1-Induced Pulmonary Vasoreactivity Is Regulated by ETA and ETB Receptor Interactions

A. Caron, É. Thorin, J. Dupuis, 2007, Journal of Vascular Research.

Etiology-specific endothelin-1 clearance in human precapillary pulmonary hypertension.

M. Baron, A. Hirsch, D. Langleben, 2006, Chest.

Effectiveness of a Nonselective ETA/B and a Selective ETA Antagonist in Rats With Monocrotaline-Induced Pulmonary Hypertension

J. Dupuis, J. Jasmin, P. Cernacek, 2001 .

Spermine on Endothelial Extracellular Vesicles Mediates Smoking-Induced Pulmonary Hypertension Partially Through Calcium-Sensing Receptor

Z. Jing, W. Xiong, Ming-Lin Liu, 2019, Arteriosclerosis, thrombosis, and vascular biology.

Effect of ETAReceptor Antagonist on Pulmonary Hypertension and Vascular Reactivity in Rats With Congestive Heart Failure

J. Dupuis, J. Jasmin, M. Lucas, 2001 .

Long-Chain Acylcarnitines and Monounsaturated Fatty Acids Discriminate Heart Failure Patients According to Pulmonary Hypertension Status

A. Ducharme, J. Tardif, C. Des Rosiers, 2021, Metabolites.

Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial

D. Gaudet, S. Lévesque, J. Tardif, 2021, The Lancet Respiratory Medicine.

Efficacy of Colchicine in Non-Hospitalized Patients with COVID-19

D. Gaudet, S. Lévesque, J. Tardif, 2021, medRxiv.

Colchicine reduces lung injury in experimental acute respiratory distress syndrome

J. Tardif, É. Rhéaume, D. Rhainds, 2020, PloS one.

PBI-4050 Reduces Pulmonary Hypertension, Lung fibrosis and Right Ventricular Dysfunction in Heart Failure.

J. Tardif, B. Grouix, P. Laurin, 2019, Cardiovascular research.

Beneficial effects of atorvastatin on lung structural remodeling and function in ischemic heart failure.

A. Ducharme, J. Tardif, Yanfen Shi, 2010, Journal of cardiac failure.

Inhaled epoprostenol (prostacyclin) and pulmonary hypertension before cardiac surgery.

A. Denault, S. Bélisle, D. Babin, 2003, The Journal of thoracic and cardiovascular surgery.

The ETA-Receptor Antagonist LU 135252 Prevents the Progression of Established Pulmonary Hypertension Induced by Monocrotaline in Rats

J. Dupuis, S. Prié, 1999, Journal of cardiovascular pharmacology and therapeutics.

Endothelial and Epithelial Cell Transition to a Mesenchymal Phenotype Was Delineated by Nestin Expression

J. Dupuis, L. Villeneuve, E. Bissonnette, 2016, Journal of cellular physiology.

Endothelin receptor antagonists and their developing role in cardiovascular therapeutics.

J. Dupuis, 2000, The Canadian journal of cardiology.

Pulmonary production of osteopontin in humans: effects of left ventricular systolic dysfunction and cardiopulmonary bypass.

A. Denault, J. Dupuis, A. Deschamps, 2013, Journal of cardiac failure.

Endothelin-1 myocardial clearance, production, and effect on capillary permeability in vivo.

D. Stewart, C. Rose, C. Goresky, 1996, The American journal of physiology.

Endothelin-receptor antagonists in pulmonary hypertension

J. Dupuis, 2001, The Lancet.

Resident Nestin+ Neural-Like Cells and Fibers Are Detected in Normal and Damaged Rat Myocardium

J. Dupuis, L. Villeneuve, L. Manganas, 2005, Hypertension.

Endothelin-1 regulates tone of isolated small arteries in the rat: effect of hyperendothelinemia.

É. Thorin, J. Dupuis, P. Cernacek, 1998, Hypertension.

Intravascular ultrasound assessment of pulmonary vascular disease in patients with pulmonary hypertension.

J. Tardif, E. Bressollette, J. Dupuis, 1996, Chest.

EndothelinA receptor blockade improves nitric oxide-mediated vasodilation in monocrotaline-induced pulmonary hypertension.

D. Stewart, J. Dupuis, S. Prié, 1998, Circulation.

MiR-1249 on Endothelial Extracellular Vesicles Mediates Cigarette Smoke–Induced Pulmonary Hypertension by Inhibiting HDAC10 (Histone Deacetylase 10)-NFκB (Nuclear Factor κB)-CaSR (Calcium-Sensing Receptor) Cascade

Linbo Yuan, J. Dupuis, Li-ping Zhu, 2022, Hypertension.

Cardiopulmonary bypass is associated with altered vascular reactivity of isolated pulmonary artery in a porcine model: therapeutic potential of inhaled tezosentan.

A. Denault, M. Carrier, J. Dupuis, 2014, Journal of cardiothoracic and vascular anesthesia.

Effectiveness of a nonselective ET(A/B) and a selective ET(A) antagonist in rats with monocrotaline-induced pulmonary hypertension.

J. Dupuis, J. Jasmin, P. Cernacek, 2001, Circulation.

Importance of local production of endothelin-1 and of the ET(B)Receptor in the regulation of pulmonary vascular tone.

J. Dupuis, J. Jasmin, P. Cernacek, 2000, Pulmonary pharmacology & therapeutics.

Kinetics of endothelin-1 binding in the dog liver microcirculation in vivo.

D. Stewart, C. Goresky, J. Dupuis, 1999, American journal of physiology. Gastrointestinal and liver physiology.

Kinetics of endothelin-1 binding in the dog liver microcirculation in vivo.

D. Stewart, C. Goresky, J. Dupuis, 1999, The American journal of physiology.

Echocardiographic validation of pulmonary hypertension due to heart failure with reduced ejection fraction in mice

J. Tardif, Yanfen Shi, J. Dupuis, 2018, Scientific Reports.

A Newly Discovered Antifibrotic Pathway Regulated by Two Fatty Acid Receptors: GPR40 and GPR84.

J. Richard, R. Hébert, B. Grouix, 2018, The American journal of pathology.

Orally‐administrated mitochondria attenuate pulmonary hypertension with the aid of erythrocytes as carriers

Jian-sha Li, Jie Liu, J. Dupuis, 2022, Clinical and translational medicine.

Cholesterol Reduction Rapidly Improves Endothelial Function After Acute Coronary Syndromes

J. Tardif, P. Théroux, J. Dupuis, 1998 .

Al[18F]F-complexation of DFH17, a NOTA-conjugated adrenomedullin analog, for PET imaging of pulmonary circulation.

M. Létourneau, A. Fournier, J. DaSilva, 2018, Nuclear medicine and biology.

Intravascular Ultrasound Assessment of Pulmonary Vascular Disease in Patients With Pulmonary Hypertension

J. Tardif, E. Bressollette, J. Dupuis, 2001 .

Fourteen-Day Evolution of COVID-19 Symptoms during the Third Wave in Nonvaccinated Subjects and Effects of Hesperidin Therapy: A Randomized, Double-Blinded, Placebo-Controlled Study

J. Tardif, P. Laurin, L. Gagnon, 2022, Evidence-based complementary and alternative medicine : eCAM.

Mobile detection system to evaluate reactive hyperemia using radionuclide plethysmography

P. Khairy, J. Dupuis, F. Harel, 2007, Physiological measurement.

Nestin is a Marker of Lung Remodeling Secondary to Myocardial Infarction and Type I Diabetes in the Rat

S. Nattel, C. Fiset, J. Dupuis, 2015, Journal of cellular physiology.

Near-Infrared Spectroscopy to Monitor Peripheral Blood Flow Perfusion

A. Denault, P. Khairy, J. Dupuis, 2008, Journal of Clinical Monitoring and Computing.

Kinetic analysis of pulmonary neutrophil retention in vivo using the multiple-indicator-dilution technique.

Y. Merhi, J. Dupuis, A. Schwab, 2003, Journal of applied physiology.

The research on endothelial function in women and men at risk for cardiovascular disease (REWARD) study: methodology

A. Arsenault, K. Lavoie, A. Vadeboncoeur, 2011, BMC cardiovascular disorders.

Molecular imaging of the pulmonary circulation in health and disease

J. Dupuis, F. Harel, Q. Nguyen, 2014, Clinical and Translational Imaging.

Molecular Imaging of Monocrotaline-Induced Pulmonary Vascular Disease with Radiolabeled Linear Adrenomedullin

M. Létourneau, A. Fournier, J. Dupuis, 2009, Journal of Nuclear Medicine.

Lung capillary injury and repair in left heart disease: a new target for therapy?

J. Dupuis, Sayena Azarbar, 2014, Clinical science.

Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial.

J. Tardif, P. Théroux, J. Dupuis, 1999, Circulation.

Radionuclide plethysmography for noninvasive evaluation of peripheral arterial blood flow.

J. Grégoire, J. Dupuis, F. Harel, 2005, American journal of physiology. Heart and circulatory physiology.

Randomized Controlled Trial of Tailored Nursing Interventions to Improve Cardiac Rehabilitation Enrollment

S. Cossette, N. Frasure-smith, M. Guertin, 2012, Nursing research.

Absence of Association Between Infectious Agents and Endothelial Function in Healthy Young Men

J. Brophy, J. Tardif, P. Khairy, 2003, Circulation.

Institute Working Group on Cellular and Molecular Mechanisms of Right Heart Failure Right Ventricular Function and Failure : Report of a National Heart, Lung, and Blood

Robyn J. Barst, Leslie A. Leinwand, Carlin S. Long, 2022 .

Effects of early treatment with statins on short-term clinical outcomes in acute coronary syndromes: a meta-analysis of randomized controlled trials.

J. D. de Lemos, M. Briel, F. D. den Hartog, 2006, JAMA.

Characterization and reproducibility of forearm arterial flow during reactive hyperemia

P. Khairy, J. Dupuis, F. Harel, 2010, Physiological measurement.

Randomized trial comparing intravenous nitroglycerin and heparin for treatment of unstable angina secondary to restenosis after coronary artery angioplasty.

S. Nattel, J. Tardif, J. Tardif, 2000, Circulation.

Upstream use of tirofiban in patients admitted for an acute coronary syndrome in hospitals with or without facilities for invasive management. PRISM-PLUS Investigators.

P. Théroux, T. Huynh, D. Grandmont, 2001, American Journal of Cardiology.

Demographics, treatment and outcome of acute coronary syndromes: 17 years of experience in a specialized cardiac centre.

P. Théroux, J. Tanguay, J. Grégoire, 2006, The Canadian journal of cardiology.

Positive and Negative Affect Is Related to Experiencing Chest Pain During Exercise-Induced Myocardial Ischemia

A. Arsenault, K. Lavoie, S. Bacon, 2017, Psychosomatic medicine.

Enhancing Insights into Pulmonary Vascular Disease through a Precision Medicine Approach. A Joint NHLBI-Cardiovascular Medical Research and Education Fund Workshop Report.

Sanjiv J. Shah, M. Gladwin, G. Beck, 2017, American journal of respiratory and critical care medicine.

Association Between Clinical Depression and Endothelial Function Measured by Forearm Hyperemic Reactivity

A. Arsenault, K. Lavoie, S. Bacon, 2010, Psychosomatic medicine.

Quantitative hyperemic reactivity in opposed limbs during myocardial perfusion imaging: a new marker of coronary artery disease.

A. Arsenault, J. Grégoire, C. Staniloae, 2004, Journal of the American College of Cardiology.

Comparison of nitroglycerin lingual spray and sublingual tablet on time of onset and duration of brachial artery vasodilation in normal subjects.

J. Tardif, J. Dupuis, F. Harel, 1999, The American journal of cardiology.

Arterial flow measurements during reactive hyperemia using NIRS

Nina Olamaei, Paul Khairy, P. Khairy, 2008, Physiological measurement.

Thirty-year trends and outcome of isolated versus combined group 2 pulmonary hypertension after cardiac transplantation

A. Ducharme, M. Carrier, M. White, 2022, Frontiers in Cardiovascular Medicine.

The orally active ET(A) receptor antagonist (+)-(S)-2-(4,6-dimethoxy-pyrimidin-2-yloxy)-3-methoxy-3,3-diphe nyl-propionic acid (LU 135252) prevents the development of pulmonary hypertension and endothelial metabolic dysfunction in monocrotaline-treated rats.

J. Dupuis, J. Ryan, T. Leung, 1997, The Journal of pharmacology and experimental therapeutics.

Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational Research Programme in AF (EORP-AF) General Long-Term Registry

H. Heidbuchel, D. Atar, J. Le Heuzey, 2021, BMC Medicine.

PulmoBind Imaging Measures Reduction of Vascular Adrenomedullin Receptor Activity with Lack of effect of Sildenafil in Pulmonary Hypertension

J. Tardif, M. Létourneau, A. Fournier, 2019, Scientific Reports.

Lung remodeling and pulmonary hypertension after myocardial infarction: pathogenic role of reduced caveolin expression.

M. Lisanti, H. Tanowitz, I. Mercier, 2004, Cardiovascular research.

SPECT and PET imaging of adrenomedullin receptors: a promising strategy for studying pulmonary vascular diseases.

M. Létourneau, A. Fournier, J. DaSilva, 2019, American journal of nuclear medicine and molecular imaging.

Radioreceptor assay of an endothelin A receptor antagonist in plasma and urine.

J. Rouleau, L. Franchi, J. Dupuis, 1998, Clinical chemistry.

Evaluation of a Web-Based Tailored Nursing Intervention (TAVIE en m@rche) Aimed at Increasing Walking After an Acute Coronary Syndrome: A Multicenter Randomized Controlled Trial Protocol

S. Cossette, Marc-André Maheu-Cadotte, J. Côté, 2017, JMIR research protocols.

Peptide Blocking Self-Polymerization of Extracellular Calcium-Sensing Receptor Attenuates Hypoxia-Induced Pulmonary Hypertension

J. Dupuis, Li-ping Zhu, Q. Hu, 2021, Hypertension.

Right ventricular function and its coupling to pulmonary circulation predicts exercise tolerance in systolic heart failure

A. Ducharme, M. White, N. Bouabdallaoui, 2021, ESC heart failure.

Relative associations between depression and anxiety on adverse cardiovascular events: does a history of coronary artery disease matter? A prospective observational study

A. Arsenault, K. Lavoie, S. Bacon, 2015, BMJ Open.

A Novel Molecular Pathway of Plaque Vulnerability Reveals a Cholesterol-Independent Effect of Statins and Supports Inflammation as a Therapeutic Target.

É. Thorin, J. Dupuis, Pauline Mury, 2020, The Canadian journal of cardiology.

[Comparison of lansoprazole (30 mg) and omeprazole (20 mg) in the treatment of duodenal ulcer. A multicenter double-blind comparative trial].

J. Grimaud, J. Dupuis, J. Andrieu, 1993, Gastroenterologie clinique et biologique.

Pulmonary endothelin-1 clearance in human pulmonary arterial hypertension.

A. Hirsch, D. Langleben, A. Caron, 2005, Chest.

Co-profiling reveals distinct patterns of genomic chromatin accessibility and gene expression in pulmonary hypertension caused by chronic hypoxia

J. Dupuis, Han Zhang, Q. Hu, 2023, Respiratory Research.

A web-based tailored nursing intervention (TAVIE en m@rche) aimed at increasing walking after an acute coronary syndrome: Multicenter randomized trial.

G. Fontaine, S. Cossette, Marc-André Maheu-Cadotte, 2019, Journal of advanced nursing.

Tolerance to intravenous nitroglycerin in patients with congestive heart failure: role of increased intravascular volume, neurohumoral activation and lack of prevention with N-acetylcysteine.

J. Rouleau, J. Dupuis, R. Lemieux, 1990, Journal of the American College of Cardiology.

2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Focused Update of the Guidelines for the Use of Antiplatelet Therapy.

J. Douketis, P. Armstrong, A. Bagai, 2017, The Canadian journal of cardiology.

2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Focused Update of the Guidelines for the Use of Antiplatelet Therapy.

J. Douketis, P. Armstrong, A. Bagai, 2017, Canadian Journal of Cardiology.

Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure.

M. Gladwin, C. Long, L. Leinwand, 2006, Circulation.

Abstract 526: Short Term Administration of a Cell Permeable Caveolin-1 Peptide Prevents the Development of Pulmonary Hypertension and Right Ventricular Hypertrophy

M. Lisanti, H. Tanowitz, I. Mercier, 2006 .

Mechanisms of acute coronary syndromes and the potential role of statins.

J. Dupuis, 2001, Atherosclerosis. Supplements.